30 Stocks Moving In Friday's Mid-Day Session

Gainers

• CLPS Incorporation CLPS shares jumped 57.2 percent to $9.5852 after climbing 19.84 percent on Thursday.
• Avalara, Inc. AVLR surged 53 percent to $36.74. Avalara priced its IPO at $24 per share.
• Ambow Education Holding Ltd. AMBO shares rose 34.8 percent to $5.53.
• Verrica Pharmaceuticals Inc. VRCA gained 23.4 percent to $18.515. Verrica Pharma priced its IPO at $15 per share.
• Canada Goose Holdings Inc. GOOS shares climbed 22.5 percent to $56.18 following Q4 results. Canada Goose posted Q4 earnings of $0.09 per share on sales of $124.821 million.
• Verrica Pharmaceuticals Inc. VRCA rose 20 percent to $18.00. Verrica priced its IPO at $15 per share.
• Braskem S.A. BAK shares gained 19.2 percent to $25.9301. LyondellBasell and Odebrecht have entered exclusive discussions related to a potential deal for Braskem.
• Verastem Inc VSTM shares gained 16.7 percent to $6.51. Verastem reported a $43 million common stock offering at $6 per share.
• Hancock Jaffe Laboratories, Inc. HJLI climbed 9.6 percent to $4.58.
• Boxlight Corporation BOXL gained 7.1 percent to $6.20. Boxlight will join the Russell Microcap® Index on June 25.
• ContraFect Corporation CFRX rose 6.2 percent to $2.12. Chardan Capital initiated coverage on ContraFect with a Buy rating.
• Dr. Reddy's Laboratories Limited RDY rose 6.1 percent to $35.025. The global pharmaceutical company said it received final approval from the FDA for its uprenorphine and Naloxone Sublingual Film which is used to treat adults with opioid dependence/addiction.
• Hexindai Inc. HX rose 5.3 percent to $12.07 after reporting Q4 results.
• Jerash Holdings (US), Inc. JRSH gained 4.7 percent to $8.16.

Check out these big penny stock gainers and losers

Losers

• Achieve Life Sciences, Inc. ACHV fell 30.4 percent to $3.62 after reporting pricing of $12 million underwritten public offering.
• Affimed N.V. AFMD declined 18.1 percent to $2.007 after the release of updated data on its Hodgkin lymphoma treatment candidate. Affimed made a poster presentation at the European Hematology Association Congress of new interim data from a Phase 1b dose escalation study that evaluated AFM13, its lead NK cell engager candidate, in combination with Merck & Co., Inc. MRK's Keytruda for relapsed/refractory Hodgkin lymphoma.
• Global Blood Therapeutics, Inc. GBT shares fell 12.8 percent to $41.05 after announcing new Phase 2a voxelotor data in adolescents with sickle cell disease at the EHA 2018.
• Euro Tech Holdings Company Limited CLWT dropped 12.2 percent to $5.3115.
• InfoSonics Corporation IFON dropped 10.3 percent to $3.24.
• Jabil Inc. JBL fell 9.6 percent to $26.81. Jabil reported stronger-than-expected earnings for its third quarter on Thursday.
• Genco Shipping & Trading Limited GNK dropped 9 percent to $16.54. Genco Shipping priced 6.1 million shares at $16.50 per share.
• Warrior Met Coal, Inc. HCC declined 9 percent to $25.01.
• Avalon Holdings Corporation AWX dropped 8.6 percent to $2.1973.
• Cherokee Inc. CHKE fell 8.1 percent to $0.781 after the company reported mixed Q1 earnings and issued downbeat FY19 sales guidance.
• Canadian Solar Inc. CSIQ dropped 7.7 percent to $11.50.
• LG Display Co., Ltd. LPL shares fell 7.5 percent to $9.505.
• Sierra Oncology Inc SRRA fell 7.2 percent to $3.295. Sierra Oncology disclosed a $200 million mixed securities shelf offering.
• Coda Octopus Group, Inc. CODA slipped 5.7 percent to $3.60 following Q2 results.
• AMAG Pharmaceuticals, Inc. AMAG dropped 4.3 percent to $23.700 after the company reported divestiture of Cord Blood Registry to GI Partners for $530 million in cash. Janney Capital downgraded AMAG Pharmaceuticals from Buy to Neutral
• Cision Ltd. CISN shares fell 3.5 percent to $15.19. Cision priced its 12 million share offering by selling shareholders at $15.00 per share.